<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Allozyne, Developer of Multiple Sclerosis Drug in Fewer Shots, Poised to Enter Clinical Trials</title>
	<atom:link href="http://www.xconomy.com/seattle/2008/10/16/allozyne-developer-of-multiple-sclerosis-drug-in-fewer-shots-poised-to-enter-clinical-trials/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2008/10/16/allozyne-developer-of-multiple-sclerosis-drug-in-fewer-shots-poised-to-enter-clinical-trials/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 21 Nov 2009 22:30:41 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>
